First study into the effects of MDMA on the resting brain
(Medical Xpress) -- Researchers from UCL and Imperial College London are carrying out a neuroscience study to examine for the first time how the resting brain responds to MDMA, the pure form of the Class A drug ecstasy. The study is funded by Channel 4, and recorded footage of it will be shown on two new science programs this autumn, Drugs Live: The Ecstasy Trial, alongside a live studio debate to explore issues linked with MDMA.
The research uses functional magnetic resonance imaging (fMRI) to examine the effects of MDMA in healthy volunteers under laboratory conditions. Volunteers are supervised by medical staff, before undergoing an fMRI brain scan and a series of cognitive tests to examine MDMAs effects on empathy, trust and memory. In addition to providing fundamental information on how MDMA affects the resting brain, results from the study might also inform future research into whether the drug could be of use as a clinical treatment.
The study has been designed by psychopharmacologists Professor Val Curran from UCLs Department of Clinical, Educational, and Health Psychology and Professor David Nutt from Imperial College London.
Professor Curran said: "Ecstasy has been used as a recreational drug since it hit the rave scene in the late 1980s. In all those years, surprisingly few controlled, scientific studies have analysed its effects upon humans.
"This new study looks at the effects of MDMA on an individual's brain and behavior. How does it affect empathy - our ability to put ourselves in someone else's shoes? And how does it affect the level of trust we place in other people and our socializing with them? This study investigates how people are affected not only immediately after taking MDMA but also during the following days as they deal with the 'come down' effect of the drug leaving their system.
"Giving people balanced, evidence-based information about the effects of drugs is crucial if we want them to make informed personal and political decisions about drug use. These programmes will provide a unique opportunity to share the science of MDMA."
Professor Nutt, the Edmond J. Safra Professor of Neuropsychopharmacology in the Division of Brain Sciences at Imperial College London, said: Nearly half a million people are believed to take ecstasy every year in the UK, but there has been very little research into what it does in the brain. This is the first study that will involve brain scans of people taking MDMA while not performing any tasks. Imaging technology has improved enormously recently, so these experiments will give us a much clearer picture of the fundamental effects of MDMA on the resting brain than anyone has been able to get before.
The context in which people will take MDMA in this study will be very different and much safer than the context in which people use it recreationally, with a controlled dose, a pure sample of the drug, absence of any other drugs or alcohol, and a doctor monitoring their health. This means the study wont tell us whether its safe to take ecstasy in a club, but it will improve our understanding of how MDMA achieves its psychoactive effects. This will help people to make decisions about drug-taking with more information about its potential harms and how to reduce the risks. It could also help inform discussions about potential clinical uses of the drug, which could be tested in later studies.
The study has received the ethical approval required for research involving healthy volunteers, who were all screened by medics and psychiatrists before giving their fully-informed consent to take part. Professors Curran and Nutt retain control over the research, which they plan to submit for publication in a peer-reviewed scientific journal.
The Channel 4 programs, provisionally titled 'Drugs Live: The Ecstasy Trial', will provide detailed analysis of the neurological and psychological effects of MDMA, the potential risks and consequences of taking the drug both in the short and long-term, and explore the new research into potential therapeutic benefits of MDMA.
The live studio debate to be screened alongside footage from the study will feature people representing a wide range of views on the issues, including scientists, police, politicians and campaigners, as well as members of the public. The programs will be accompanied by extensive online resources and links to support and advice.
Channel 4 Senior Commissioning Editor, David Glover, said: The use of controlled drugs, including ecstasy, is a hugely important issue and Britain has been called the drug-taking capital of Europe. But too often the facts and particularly the science can become lost in the heat of the argument.
These programs will feature a scientific study that aims to demonstrate the effects of using ecstasy on the brain and behavior alongside a grown-up debate about the issues raised featuring a wide range of views.
More information: The programs, which are being made by Renegade Productions, will be shown this autumn on Channel 4. The executive producer is Alan Hayling and the Program Editor is Liz Foley.
Provided by University College London
- Taking the party out of ecstasy - a strategy for new Parkinson's disease drugs? Jun 14, 2012 | not rated yet | 0
- MDMA: Empathogen or love potion? Dec 15, 2010 | not rated yet | 0
- Ecstasy derivative targets blood cancers Oct 06, 2011 | not rated yet | 0
- Ecstasy drug produces lasting toxicity in the brain Dec 05, 2011 | not rated yet | 0
- Cocaine or ecstasy consumption during adolescence increases risk of addiction Feb 04, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
15 hours ago From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
Medical research May 17, 2013 | 3.7 / 5 (3) | 0 |
Scientists investigating the interaction of a group of proteins in the brain responsible for protecting nerve cells from damage have identified a new target that could increase cell survival.
Medical research May 17, 2013 | 5 / 5 (1) | 0
New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin ...
Medical research May 17, 2013 | not rated yet | 0 |
Peptide molecules derived from the body's natural immune system can help boost the body's defence against life-threatening blood poisoning, joint University research has uncovered.
Medical research May 17, 2013 | 4 / 5 (1) | 0 |
A new Montréal study conducted by Dr. May Faraj, associate research professor at the Université de Montréal and invited scientist at the IRCM, along with her research team and medical collaborators, shows ...
Medical research May 17, 2013 | not rated yet | 0 |
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
8 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
6 hours ago | not rated yet | 0
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
6 hours ago | not rated yet | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
16 hours ago | 5 / 5 (1) | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
17 hours ago | 5 / 5 (1) | 0 |
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
8 hours ago | 5 / 5 (1) | 0